For much of the past three decades in the democratic era, South African business has found itself in a position of lobbying government leaders to pursue that policies that meet the demands of both industry and the nation’s critical development objectives. During the HIV/Aids crisis of the early 2000s, leaders in the pharmaceutical industry were … Continue reading